RGLS $0.00 ( +0.00%) Quote details

stock

Regulus Therapeutics Inc

NASDAQ | RGLS

3.49

USD

+0.00 ( +0.00%)

AT CLOSE (AS OF Apr 28, 2025)

$185M

MARKET CAP

-

P/E Ratio

-0.82

EPS

$3.7

52 Week High

$0.83

52 Week Low

LIFE SCIENCES

Sector

RGLS Chart

1D
Area

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

RGLS Technicals

Tags:

RGLS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$50M
Selling General And Administrative $15M
Research And Development $35M
Operating Expenses $50M
Investment Income Net -
Net Interest Income $3.7M
Interest Income $3.8M
Interest Expense $158K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $347K
Income Before Tax -$46M
Income Tax Expense $1K
Interest And Debt Expense -
Net Income From Continuing Operations -$46M
Comprehensive Income Net Of Tax -
Ebit -$46M
Ebitda -$46M
Net Income -$46M

Revenue & Profitability

Earnings Performance

RGLS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $84M
Total Current Assets $82M
Cash And Cash Equivalents At Carrying Value $39M
Cash And Short Term Investments $39M
Inventory -
Current Net Receivables -
Total Non Current Assets $1.8M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $25K
Intangible Assets Excluding Goodwill $25K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $37M
Other Current Assets $6.6M
Other Non Current Assets -
Total Liabilities $7.8M
Total Current Liabilities $7.5M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $274K
Capital Lease Obligations $274K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $274K
Other Current Liabilities $6.6M
Other Non Current Liabilities -
Total Shareholder Equity $76M
Treasury Stock -
Retained Earnings -$560M
Common Stock $66K
Common Stock Shares Outstanding $56M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$42M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -$1.2M
Capital Expenditures $340K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $92M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$69K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$46M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$50M
Selling General And Administrative $15M
Research And Development $35M
Operating Expenses $50M
Investment Income Net -
Net Interest Income $3.7M
Interest Income $3.8M
Interest Expense $158K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $347K
Income Before Tax -$46M
Income Tax Expense $1K
Interest And Debt Expense -
Net Income From Continuing Operations -$46M
Comprehensive Income Net Of Tax -
Ebit -$46M
Ebitda -$46M
Net Income -$46M

RGLS News

RGLS Profile

Regulus Therapeutics Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of drugs that target microRNAs to treat a variety of diseases in the United States. The company is headquartered in San Diego, California.

AGMH
175.72%
$0.134
LGMK
48.28%
$0.0129
DMN
8.57%
$0.0038
DGLY
12.10%
$0.0315
PTPI
7.22%
$0.0579
GNLN
-3.23%
$0.012
PLUG
25.68%
$1.02
NVDA
-2.05%
$108.73
TSLA
0.33%
$285.88
WW
4.52%
$0.4135
OMEX
-12.58%
$1.32
PLTR
1.66%
$114.65
INTC
2.29%
$20.51
SOFI
2.48%
$13.2
BON
13.24%
$0.065
F
-0.20%
$10.02
LCID
1.20%
$2.53
PONY
47.22%
$10.32
AZUL
6.01%
$0.88
DNN
5.04%
$1.46
GLMD
6.37%
$1.67
NIO
6.95%
$4.31
AAL
1.03%
$9.85
PFE
0.57%
$23.05
LYT
-16.78%
$0.0982
SNAP
3.40%
$8.83
WULF
0.67%
$3.02
BTG
0.32%
$3.09
GRAB
-0.42%
$4.76
SMCI
2.19%
$37.27
AAPL
0.41%
$210.14
WBD
1.28%
$8.7
BAC
0.23%
$39.78
HOOD
-1.05%
$48.93
JBLU
4.90%
$4.07
RIVN
4.52%
$13.19
AMZN
-0.68%
$187.7
HIMS
1.39%
$28.48
AMCR
0.94%
$9.63
ABEV
0.81%
$2.49
RGTI
-1.60%
$9.22
AMD
-0.26%
$96.39
RIG
-0.86%
$2.31
MARA
-2.03%
$14.01
RIOT
-1.80%
$7.63
AGNC
1.92%
$9.02
ERIC
0.61%
$8.24
QBTS
-2.12%
$7.37
APLD
0.21%
$4.71
ME
-21.26%
$0.6063
GOOGL
-0.83%
$160.61
CUTR
-10.19%
$0.0969
ONCO
14.45%
$0.08
FFAI
24.76%
$1.31
MLGO
-10.23%
$7.11
AVTR
-3.40%
$12.49
PMAX
7.30%
$0.4216
T
1.68%
$27.26
SAG
42.57%
$1.44
LYG
0.51%
$3.96
CLSK
-4.88%
$8.57
CSCO
0.23%
$56.84
VALE
1.05%
$9.6
ITUB
1.14%
$6.21
NAAS
-20.50%
$1.45
BTE
0.61%
$1.66
BBD
0.42%
$2.39
GOOG
-0.87%
$162.42
KGC
2.00%
$14.78
NGD
-0.59%
$3.37
SOUN
2.31%
$9.74
GNPX
2.88%
$0.293
FNA
0.00%
$13.09
IQ
-1.56%
$1.89
KHC
-2.31%
$28.81
VRN
0.98%
$6.19
BTOG
4.10%
$0.16
BMY
1.17%
$48.46
AG
0.81%
$6.24
GWAV
12.13%
$0.196
CMG
-1.70%
$50.9
CCL
1.40%
$18.86
TGB
3.95%
$2.37
HL
0.34%
$5.87
NOK
-1.60%
$4.91
MU
-1.53%
$78.56
WFC
-0.43%
$69.43
MSFT
-0.18%
$391.16
AVGO
0.08%
$192.47
IAG
2.28%
$7.19
ACHR
-0.70%
$8.53
BITF
-0.97%
$1.02
AEG
1.24%
$6.53
VZ
1.15%
$42.39
KO
-0.17%
$71.79
AUR
5.52%
$7.26
PBR
0.26%
$11.51
RLMD
-44.64%
$0.3571
HTZ
2.53%
$8.51
TLRY
-2.09%
$0.4769
AGMH
175.72%
$0.134
LGMK
48.28%
$0.0129
DMN
8.57%
$0.0038
DGLY
12.10%
$0.0315
PTPI
7.22%
$0.0579
GNLN
-3.23%
$0.012
PLUG
25.68%
$1.02
NVDA
-2.05%
$108.73
TSLA
0.33%
$285.88
WW
4.52%
$0.4135
OMEX
-12.58%
$1.32
PLTR
1.66%
$114.65
INTC
2.29%
$20.51
SOFI
2.48%
$13.2
BON
13.24%
$0.065
F
-0.20%
$10.02
LCID
1.20%
$2.53
PONY
47.22%
$10.32
AZUL
6.01%
$0.88
DNN
5.04%
$1.46
GLMD
6.37%
$1.67
NIO
6.95%
$4.31
AAL
1.03%
$9.85
PFE
0.57%
$23.05
LYT
-16.78%
$0.0982
SNAP
3.40%
$8.83
WULF
0.67%
$3.02
BTG
0.32%
$3.09
GRAB
-0.42%
$4.76
SMCI
2.19%
$37.27
AAPL
0.41%
$210.14
WBD
1.28%
$8.7
BAC
0.23%
$39.78
HOOD
-1.05%
$48.93
JBLU
4.90%
$4.07
RIVN
4.52%
$13.19
AMZN
-0.68%
$187.7
HIMS
1.39%
$28.48
AMCR
0.94%
$9.63
ABEV
0.81%
$2.49
RGTI
-1.60%
$9.22
AMD
-0.26%
$96.39
RIG
-0.86%
$2.31
MARA
-2.03%
$14.01
RIOT
-1.80%
$7.63
AGNC
1.92%
$9.02
ERIC
0.61%
$8.24
QBTS
-2.12%
$7.37
APLD
0.21%
$4.71
ME
-21.26%
$0.6063
GOOGL
-0.83%
$160.61
CUTR
-10.19%
$0.0969
ONCO
14.45%
$0.08
FFAI
24.76%
$1.31
MLGO
-10.23%
$7.11
AVTR
-3.40%
$12.49
PMAX
7.30%
$0.4216
T
1.68%
$27.26
SAG
42.57%
$1.44
LYG
0.51%
$3.96
CLSK
-4.88%
$8.57
CSCO
0.23%
$56.84
VALE
1.05%
$9.6
ITUB
1.14%
$6.21
NAAS
-20.50%
$1.45
BTE
0.61%
$1.66
BBD
0.42%
$2.39
GOOG
-0.87%
$162.42
KGC
2.00%
$14.78
NGD
-0.59%
$3.37
SOUN
2.31%
$9.74
GNPX
2.88%
$0.293
FNA
0.00%
$13.09
IQ
-1.56%
$1.89
KHC
-2.31%
$28.81
VRN
0.98%
$6.19
BTOG
4.10%
$0.16
BMY
1.17%
$48.46
AG
0.81%
$6.24
GWAV
12.13%
$0.196
CMG
-1.70%
$50.9
CCL
1.40%
$18.86
TGB
3.95%
$2.37
HL
0.34%
$5.87
NOK
-1.60%
$4.91
MU
-1.53%
$78.56
WFC
-0.43%
$69.43
MSFT
-0.18%
$391.16
AVGO
0.08%
$192.47
IAG
2.28%
$7.19
ACHR
-0.70%
$8.53
BITF
-0.97%
$1.02
AEG
1.24%
$6.53
VZ
1.15%
$42.39
KO
-0.17%
$71.79
AUR
5.52%
$7.26
PBR
0.26%
$11.51
RLMD
-44.64%
$0.3571
HTZ
2.53%
$8.51
TLRY
-2.09%
$0.4769
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.